Intended for healthcare professionals


NICE faces legal challenge over Alzheimer's drug

BMJ 2007; 334 doi: (Published 29 March 2007) Cite this as: BMJ 2007;334:654
  1. Clare Dyer, legal correspondent
  1. BMJ

    The National Institute for Health and Clinical Excellence (NICE), the NHS drugs gatekeeper for England and Wales, faces the first legal challenge to one of its decisions restricting the use of a drug by the NHS.

    The High Court gave the go ahead this week to a drug company to bring judicial review proceedings over restrictions on the use of donepezil (Aricept), which is used to treat Alzheimer's disease.

    Guidance from NICE, which does cost-benefit …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription